Skip to content

OUTLOOK THERAPEUTICS, INC.: 10-Q filed 2016-06-27

What OUTLOOK THERAPEUTICS, INC. reported in its quarterly report filed 2016-06-27 (fiscal Q2 2016): 38 published measures, 98 facts as tagged in accession 0001571049-16-016287.

This filing

Form
10-Q (quarterly report)
Filed
2016-06-27
Fiscal period
fiscal Q2 2016
Accession
0001571049-16-016287 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OUTLOOK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-03-3124,831,451USD
At 2015-09-3035,008,621USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-03-3145,299,698USD
At 2015-09-3062,561,113USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-03-31-37,864,873USD
At 2015-09-30-54,219,386USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-03-312,842,194USD
At 2015-09-309,070,975USD
At 2015-03-31425,821USD
At 2014-09-302,349,313USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-01-01 to 2016-03-31-3,542,380USD91
2015-10-01 to 2016-03-31-20,406,592USD183
2015-01-01 to 2015-03-31-13,981,376USD90
2014-10-01 to 2015-03-31-18,888,633USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-10-01 to 2016-03-31317,293USD183
2014-10-01 to 2015-03-312,020,557USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-01-01 to 2016-03-31994,894USD91
2015-10-01 to 2016-03-311,989,788USD183
2015-01-01 to 2015-03-31494,894USD90
2014-10-01 to 2015-03-313,429,449USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-03-31-114,470,878USD
At 2015-09-30-94,064,286USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-01-01 to 2016-03-3150,500USD91
2015-10-01 to 2016-03-31102,500USD183
2015-01-01 to 2015-03-31-726,218USD90
2014-10-01 to 2015-03-31-319,855USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-03-3117,358,388USD
At 2015-09-3017,759,938USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-10-01 to 2016-03-31-1,956,455USD183
2014-10-01 to 2015-03-317,175,780USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-03-31-2,953,945USD91
2015-10-01 to 2016-03-31-19,367,182USD183
2015-01-01 to 2015-03-31-14,001,665USD90
2014-10-01 to 2015-03-31-18,144,979USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-03-314,103,005USD
At 2015-09-3015,164,233USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-01-01 to 2016-03-31537,935USD91
2015-10-01 to 2016-03-31936,910USD183
2015-01-01 to 2015-03-31705,929USD90
2014-10-01 to 2015-03-311,063,509USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-03-3135,975,152USD
At 2015-09-3037,041,599USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-03-3114,416,288USD
At 2015-09-3011,563,055USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-03-31504,857USD
At 2015-09-3020,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-01-01 to 2016-03-313,948,839USD91
2015-10-01 to 2016-03-3121,356,970USD183
2015-01-01 to 2015-03-3114,496,559USD90
2014-10-01 to 2015-03-3121,574,428USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-01-01 to 2016-03-314,138,277USD91
2015-10-01 to 2016-03-3116,872,253USD183
2015-01-01 to 2015-03-3110,154,469USD90
2014-10-01 to 2015-03-3115,994,499USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-03-310shares
At 2015-09-309,436,294shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-03-3176,481,615USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-03-31-37,864,873USD
At 2015-09-30-54,873,803USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2016-03-312,547,139USD
At 2015-09-302,922,764USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-03-3122,118,123USD
At 2015-09-3021,403,385USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-03-314,759,735USD
At 2015-09-303,643,447USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-03-31882,877USD
At 2015-09-30910,224USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-03-31591,128USD
At 2015-09-30284,710USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-03-316,403,971USD
At 2015-09-305,924,648USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-03-31712,767USD
At 2015-09-301,793,109USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-01-01 to 2016-03-31-3,491,880USD91
2015-10-01 to 2016-03-31-20,304,092USD183
2015-01-01 to 2015-03-31-14,707,594USD90
2014-10-01 to 2015-03-31-19,208,488USD182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2016-01-01 to 2016-03-31-4,572,794USD91
2015-10-01 to 2016-03-31-22,376,545USD183
2015-01-01 to 2015-03-31-15,083,538USD90
2014-10-01 to 2015-03-31-22,292,957USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-01-01 to 2016-03-31-189,438USD91
2015-10-01 to 2016-03-314,484,717USD183
2015-01-01 to 2015-03-314,342,090USD90
2014-10-01 to 2015-03-315,579,929USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-01-01 to 2016-03-31598,097USD91
2015-10-01 to 2016-03-311,192,074USD183
2015-01-01 to 2015-03-31218,996USD90
2014-10-01 to 2015-03-31441,071USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2015-10-01 to 2016-03-31794,663USD183
2014-10-01 to 2015-03-31855,446USD182

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2015-10-01 to 2016-03-312,500USD183
2014-10-01 to 2015-03-312,250USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-10-01 to 2016-03-3116,137,913USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-10-01 to 2016-03-31484,857USD183
2014-10-01 to 2015-03-311,072,910USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-10-01 to 2016-03-311,878,794USD183
2014-10-01 to 2015-03-313,344,446USD182

Inspect the source

Entity
OUTLOOK THERAPEUTICS, INC. / CIK 0001649989
Captured
2026-09-21T17:23:24.422Z
SEC response SHA-256
ce697e8c1ac203fe6827508f0d6a14f8a445ce42f9c031026a98c3f5635933f0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001649989.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))